{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:44:58Z","timestamp":1790876698046,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,30]],"date-time":"2027-04-30T00:00:00Z","timestamp":1809043200000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5T32GM132055-07"],"award-info":[{"award-number":["5T32GM132055-07"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["RX000444"],"award-info":[{"award-number":["RX000444"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX003050"],"award-info":[{"award-number":["BX003050"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK6 BX004858"],"award-info":[{"award-number":["IK6 BX004858"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY030072"],"award-info":[{"award-number":["R01EY030072"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013191","name":"South Carolina Centers of Economic Excellence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.oret.2025.12.016","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:20:02Z","timestamp":1766622002000},"page":"471-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Rate of Age-Related Macular Degeneration in Patients Prescribed Glucagon-Like Peptide-1 Receptor Agonists or Other Weight Loss Therapies"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3984-1574","authenticated-orcid":false,"given":"Walter K.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2758-3771","authenticated-orcid":false,"given":"B\u00e4rbel","family":"Rohrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.12.016_bib1","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ophtha.2015.12.026","article-title":"Incidence of age-related macular degeneration in a multi-ethnic United States population: the multi-ethnic study of atherosclerosis","volume":"123","author":"Fisher","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.12.016_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/vision9010016","article-title":"Modifiable lifestyle risk factors and strategies for slowing the progression of age-related macular degeneration","volume":"9","author":"Saigal","year":"2025","journal-title":"Vision (Basel)"},{"key":"10.1016\/j.oret.2025.12.016_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.12.004","article-title":"Nature and nurture- genes and environment- predict onset and progression of macular degeneration","volume":"40","author":"Sobrin","year":"2014","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2025.12.016_bib4","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4103\/1673-5374.335140","article-title":"Recent developments of neuroprotective agents for degenerative retinal disorders","volume":"17","author":"Ou","year":"2022","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.oret.2025.12.016_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/cells13010065","article-title":"GLP1 receptor agonists\u2014effects beyond obesity and diabetes","volume":"13","author":"Wilbon","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.oret.2025.12.016_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db15-0443","article-title":"Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes","volume":"65","author":"Hern\u00e1ndez","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.oret.2025.12.016_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamaophthalmol.2025.1455","article-title":"Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration","volume":"143","author":"Shor","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.12.016_bib8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ophtha.2025.01.016","article-title":"Glucagon-like peptide-1 receptor agonist impact on chronic ocular disease including age-related macular degeneration","volume":"132","author":"Allan","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.12.016_bib9","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.7326\/M24-0019","article-title":"Shifting trends in the indication of glucagon-like peptide-1 receptor agonist prescriptions: a nationwide analysis","volume":"177","author":"Yeo","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.oret.2025.12.016_bib10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ophtha.2025.02.011","article-title":"Risk of glaucoma in patients without diabetes using a glucagon-like peptide 1 receptor gonist","volume":"132","author":"Vasu","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.12.016_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1516126","article-title":"A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX","volume":"16","author":"Ludwig","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.oret.2025.12.016_bib12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/sim.6004","article-title":"A comparison of 12 algorithms for matching on the propensity score","volume":"33","author":"Austin","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.oret.2025.12.016_bib13","article-title":"TriNetX: utility functions for lucid","year":"2023","journal-title":"R package version 0.1.0"},{"key":"10.1016\/j.oret.2025.12.016_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101882","article-title":"Pharmacotherapy of obesity: an update on the available medications and drugs under investigation","volume":"58","author":"Chakhtoura","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.oret.2025.12.016_bib15","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.ophtha.2022.07.010","article-title":"Disparities in vision health and eye care","volume":"129","author":"Elam","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.12.016_bib16","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/archopht.126.11.1554","article-title":"Changes in abdominal obesity and age-related macular degeneration","volume":"126","author":"Peeters","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.12.016_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2025.4258","article-title":"Glucagon-like peptide-1 receptor agonist order fills and out-of-pocket costs by race, ethnicity, and indication","volume":"6","author":"Sarpatwari","year":"2025","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.oret.2025.12.016_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.37492","article-title":"Social risk factor domains and preventive care services in US adults","volume":"7","author":"Schroeder","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.oret.2025.12.016_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajmo.2025.100100","article-title":"Health disparity clusters of off label prescriptions for glucagon-like peptide 1 receptor agonists","volume":"13","author":"Spinelli","year":"2025","journal-title":"Am J Med Open"},{"key":"10.1016\/j.oret.2025.12.016_bib20","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1167\/iovs.15-18637","article-title":"Overweight, obesity, and risk of age-related macular degeneration","volume":"57","author":"Zhang","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.12.016_bib21","article-title":"Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2025.12.016_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/pds.70048","article-title":"Core concepts in pharmacoepidemiology: new-user designs","volume":"33","author":"Her","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.oret.2025.12.016_bib23","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Web site and R package for computing E-values","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"key":"10.1016\/j.oret.2025.12.016_bib24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.oret.2025.12.016_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/tri.13535","article-title":"To test or to estimate? P-values versus effect sizes","volume":"33","author":"Dunkler","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.oret.2025.12.016_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","article-title":"Using effect size\u2014or why the P value is not enough","volume":"4","author":"Sullivan","year":"2012","journal-title":"J Grad Med Educ"},{"key":"10.1016\/j.oret.2025.12.016_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2337\/cd20-as01","article-title":"Standards of medical care in diabetes\u20142020 abridged for primary care providers","volume":"38","year":"2020","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.oret.2025.12.016_bib28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamaophthalmol.2025.3821","article-title":"Glucagon-like peptide-1 receptor agonists and age-related macular degeneration","volume":"143","author":"Ahuja","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.12.016_bib29","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/bmj.317.7156.468","article-title":"Statistics notes: time to event (survival) data","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.oret.2025.12.016_bib30","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","article-title":"Hazard ratio in clinical trials","volume":"48","author":"Spruance","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.oret.2025.12.016_bib31","first-page":"851","article-title":"Obesity and inflammation: the linking mechanism and the complications","volume":"13","author":"Ellulu","year":"2016","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.oret.2025.12.016_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/975032","article-title":"Retinal pigment epithelial cells express a functional receptor for glucagon-like peptide-1 (GLP-1)","volume":"2013","author":"Puddu","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.oret.2025.12.016_bib33","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.3390\/ijms26083704","article-title":"Liraglutide attenuates FFA-induced retinal pigment rpithelium dysfunction via AMPK activation and lipid homeostasis regulation in ARPE-19 cells","volume":"26","author":"Tsou","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025005974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025005974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:28:18Z","timestamp":1777602498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025005974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2468653025005974"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.12.016","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rate of Age-Related Macular Degeneration in Patients Prescribed Glucagon-Like Peptide-1 Receptor Agonists or Other Weight Loss Therapies","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}